Publication | Closed Access
Nitric oxide acts independently of cGMP to modulate capacitative Ca<sup>2+</sup>entry in mouse parotid acini
48
Citations
44
References
1999
Year
Cellular PharmacologyPharmacotherapyExperimental PharmacologyCellular PhysiologyMolecular PharmacologyNitric Oxide SynthaseCell SignalingMolecular PhysiologyBiochemistryG Protein-coupled ReceptorCgmp AccumulationMechanism Of ActionMouse Parotid AciniPharmacologyCell BiologyNitric Oxide ActsSignal TransductionCgmp LevelsNeurophysiologyPhysiologyMedicineNitrosative Stress
Carbachol- and thapsigargin-induced changes in cGMP accumulation were highly dependent on extracellular Ca(2+) in mouse parotid acini. Inhibition of nitric oxide synthase (NOS) and soluble guanylate cyclase (sGC) resulted in complete inhibition of agonist-induced cGMP levels. NOS inhibitors reduced agonist-induced Ca(2+) release and capacitative Ca(2+) entry, whereas the inhibition of sGC had no effect. The effects of NOS inhibition were not reversed by 8-bromo-cGMP. The NO donor GEA-3162 increased cGMP levels blocked by the inhibition of sGC. GEA-3162-induced increases in Ca(2+) release from ryanodine-sensitive stores and enhanced capacitative Ca(2+) entry, both of which were unaffected by inhibitors of sGC but reduced by NOS inhibitors. Results support a role for NO, independent of cGMP, in agonist-mediated Ca(2+) release and Ca(2+) entry. Data suggest that agonist-induced Ca(2+) influx activates a Ca(2+)-dependent NOS, leading to the production of NO and the release of Ca(2+) from ryanodine-sensitive stores, providing a feedback loop by which store-depleted Ca(2+) channels are activated.
| Year | Citations | |
|---|---|---|
Page 1
Page 1